237 related articles for article (PubMed ID: 21637140)
1. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection.
Hönger G; Hopfer H; Arnold ML; Spriewald BM; Schaub S; Amico P
Transplantation; 2011 Jul; 92(1):41-7. PubMed ID: 21637140
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood.
Jackson AM; Lucas DP; Melancon JK; Desai NM
Transplantation; 2011 Jul; 92(1):54-60. PubMed ID: 21516064
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
[TBL] [Abstract][Full Text] [Related]
4. C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection.
Hönger G; Wahrmann M; Amico P; Hopfer H; Böhmig GA; Schaub S
Transplantation; 2010 Jun; 89(12):1471-5. PubMed ID: 20395886
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
6. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
7. Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies.
Arnold ML; Ntokou IS; Doxiadis II; Spriewald BM; Boletis JN; Iniotaki AG
Transpl Int; 2014 Mar; 27(3):253-61. PubMed ID: 24118579
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
9. Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure.
Khovanova N; Daga S; Shaikhina T; Krishnan N; Jones J; Zehnder D; Mitchell D; Higgins R; Briggs D; Lowe D
Transpl Int; 2015 Dec; 28(12):1405-15. PubMed ID: 26264744
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
[TBL] [Abstract][Full Text] [Related]
11. Determinants of the complement-fixing ability of recipient presensitization against HLA antigens.
Bartel G; Wahrmann M; Exner M; Regele H; Schillinger M; Hörl WH; Böhmig GA
Transplantation; 2007 Mar; 83(6):727-33. PubMed ID: 17414705
[TBL] [Abstract][Full Text] [Related]
12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
13. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
14. Natural history of proteinuria in renal transplant recipients developing de novo human leukocyte antigen antibodies.
Fotheringham J; Angel C; Goodwin J; Harmer AW; McKane WS
Transplantation; 2011 May; 91(9):991-6. PubMed ID: 21519315
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.
Cicciarelli JC; Kasahara N; Lemp NA; Adamson R; Dembitsky W; Browne B; Steinberg S
Clin Transpl; 2013; ():413-22. PubMed ID: 25095537
[TBL] [Abstract][Full Text] [Related]
16. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
18. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
19. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A
Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
